Agfa-Gevaert's ongoing effort to improve its profitability tookanother turn last month. The film and PACS vendor announced thatit plans to cut 550 jobs in Europe, primarily through the consolidationof its headquarters staff, which is split between
Agfa-Gevaert's ongoing effort to improve its profitability tookanother turn last month. The film and PACS vendor announced thatit plans to cut 550 jobs in Europe, primarily through the consolidationof its headquarters staff, which is split between Belgium andGermany.
Agfa's parent, German pharmaceutical giant Bayer, has crackedthe whip over Agfa for the past several years, trying to improvethe unit's profitability (SCAN 9/11/96). Agfa has cut personneland consolidated many of the company's operations in response.
In last month's announcement, Agfa said it would move centraland administrative functions now taking place in Leverkusen, Germany,to Mortsel, Belgium, where most of Agfa is headquartered, accordingto Dionn Tron, vice president of corporate communications. Agfa'sPhoto Imaging business group will remain in Leverkusen, whereit has manufacturing facilities, Tron said. The move is expectedto result in about 550 job cuts in Germany by 1997.
Agfa's U.S. subsidiary in Ridgefield Park, NJ, will not beaffected by the cuts, according to Tron. The unit began its cost-cuttingefforts several years before the Europeans.
"We've been doing this for a while and we are at the optimallevel in the U.S.," she said. "We've reduced our staff38% over the past five years."
There are signs that Agfa's cost-cutting is having the desiredimpact. Agfa's year-to-date worldwide profit margin is at 4.3%,up from 3% last year, according to Tron.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.